Cited by 762MicroRNA in disease regulationRNA Interference and Gene DeliveryCancer-related molecular mechanisms research

MicroRNA sponges: Progress and possibilities

Open access
Ebert, Margaret S., Sharp, Phillip A.·2010·RNA

Abstract

The microRNA (miRNA) "sponge" method was introduced three years ago as a means to create continuous miRNA loss of function in cell lines and transgenic organisms. Sponge RNAs contain complementary binding sites to a miRNA of interest, and are produced from transgenes within cells. As with most miRNA target genes, a sponge's binding sites are specific to the miRNA seed region, which allows them to block a whole family of related miRNAs. This transgenic approach has proven to be a useful tool to probe miRNA functions in a variety of experimental systems. Here we will discuss the ways sponge and related constructs can be optimized and review recent applications of this method with particular emphasis on stable expression in cancer studies and in transgenic animals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1261/rna.2414110

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Arvey A, Larsson E, Sander C, Leslie CS, Marks DS. 2010. Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Biol 6: 363. doi: 10.1038/msb.2010. · DOI
  2. Gatt ME, Zhao JJ, Ebert MS, Chu Z, Mani M, Gazit R, Carrasco DE, Dutta-Simmons J, Adamia S, Minvielle SB, et al. 2010. Blood (in press).
  3. Hanlon K, Rudin CE, Harries LW. 2009. Investigating the targets of MIR- 15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). PLoS ONE 4: e7169. doi: 10.1371/journal.pone.0007169. · DOI
  4. Kimchi A. 1999. Functional approaches to gene isolation in mamma- lian cells. Science 285: 299. doi: 10.1126/science.285.5426.299a. · DOI
  5. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, Dallmann I, Ganser A, Eder M. 2007. Lentivirus-mediated antag- omir expression for specific inhibition of miRNA function. Nucleic Acids Res 35: e149. doi: 10.1093/nar/gkm971. · DOI

Cited by

Sorted by citations

Authors
Ebert, M. S., & Sharp, P. A.
Affiliations
Koch Institute for Integrative Cancer Research At MIT (US)
Venue
RNA
Published
2010-09-20
Volume
16
Issue
11
Pages
2043-2050
ISSN
  • 1355-8382 (ISSN-L)
  • 1469-9001
OpenAlex
W2044601473
Cited by
762
References
5
Citations by year
2026: 13 · 2025: 36 · 2024: 40 · 2023: 46 · 2022: 48 · 2021: 58 · 2020: 55 · 2019: 73 · 2018: 45 · 2017: 55 · 2016: 52 · 2015: 67 · 2014: 56 · 2013: 45 · 2012: 41
FWCI
3.11
Type
journal article
Language
en
Open access
Locations
  • RNA (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (P30-CA14051, R01CA133404)
  • National Cancer Institute (R01CA133404, CA14051, P30CA014051, P30-CA-14051)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
microRNA sponge, miRNA seed region, transgenic animals, stable expression, cancer cell lines, microRNA function
MeSH terms
Animals, Gene Expression Regulation, Humans, Gene Transfer Techniques, Nucleic Acid Amplification Techniques, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review